These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Matthaei H; Wylie D; Lloyd MB; Dal Molin M; Kemppainen J; Mayo SC; Wolfgang CL; Schulick RD; Langfield L; Andruss BF; Adai AT; Hruban RH; Szafranska-Schwarzbach AE; Maitra A Clin Cancer Res; 2012 Sep; 18(17):4713-24. PubMed ID: 22723372 [TBL] [Abstract][Full Text] [Related]
10. Proliferation tissue polypeptide antigen distinguishes malignant mucinous cystadenocarcinomas from benign cystic tumors and pseudocysts. Yang JM; Southern JF; Warshaw AL; Lewandrowski KB Am J Surg; 1996 Jan; 171(1):126-9; discussion 129-30. PubMed ID: 8554126 [TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts. Yip-Schneider MT; Wu H; Dumas RP; Hancock BA; Agaram N; Radovich M; Schmidt CM J Am Coll Surg; 2014 Apr; 218(4):608-17. PubMed ID: 24491241 [TBL] [Abstract][Full Text] [Related]
12. Expression of CA 72-4 (TAG-72) in the fluid contents of pancreatic cysts. A new marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts. Alles AJ; Warshaw AL; Southern JF; Compton CC; Lewandrowski KB Ann Surg; 1994 Feb; 219(2):131-4. PubMed ID: 8129483 [TBL] [Abstract][Full Text] [Related]
13. Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts. Singhi AD; Nikiforova MN; Fasanella KE; McGrath KM; Pai RK; Ohori NP; Bartholow TL; Brand RE; Chennat JS; Lu X; Papachristou GI; Slivka A; Zeh HJ; Zureikat AH; Lee KK; Tsung A; Mantha GS; Khalid A Clin Cancer Res; 2014 Aug; 20(16):4381-9. PubMed ID: 24938521 [TBL] [Abstract][Full Text] [Related]
14. Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts. Jones M; Zheng Z; Wang J; Dudley J; Albanese E; Kadayifci A; Dias-Santagata D; Le L; Brugge WR; Fernandez-del Castillo C; Mino-Kenudson M; Iafrate AJ; Pitman MB Gastrointest Endosc; 2016 Jan; 83(1):140-8. PubMed ID: 26253016 [TBL] [Abstract][Full Text] [Related]
15. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. van der Waaij LA; van Dullemen HM; Porte RJ Gastrointest Endosc; 2005 Sep; 62(3):383-9. PubMed ID: 16111956 [TBL] [Abstract][Full Text] [Related]
16. Endoscopically acquired pancreatic cyst fluid microRNA 21 and 221 are associated with invasive cancer. Farrell JJ; Toste P; Wu N; Li L; Wong J; Malkhassian D; Tran LM; Wu X; Li X; Dawson D; Wu H; Donahue TR Am J Gastroenterol; 2013 Aug; 108(8):1352-9. PubMed ID: 23752880 [TBL] [Abstract][Full Text] [Related]
17. Etiologic Distribution of Pancreatic Cystic Lesions Identified on Computed Tomography/Magnetic Resonance Imaging. Munigala S; Javia SB; Agarwal B Pancreas; 2019 Sep; 48(8):1092-1097. PubMed ID: 31404022 [TBL] [Abstract][Full Text] [Related]
18. Role of biochemistry and cytological analysis of cyst fluid for the differential diagnosis of pancreatic cysts: A retrospective cohort study. Soyer OM; Baran B; Ormeci AC; Sahin D; Gokturk S; Evirgen S; Basar R; Firat P; Akyuz F; Demir K; Besisik F; Kaymakoglu S; Karaca C Medicine (Baltimore); 2017 Jan; 96(1):e5513. PubMed ID: 28072692 [TBL] [Abstract][Full Text] [Related]
19. Expression of CA 15.3 protein in the cyst contents distinguishes benign from malignant pancreatic mucinous cystic neoplasms. Rubin D; Warshaw AL; Southern JF; Pins M; Compton CC; Lewandrowski KB Surgery; 1994 Jan; 115(1):52-5. PubMed ID: 8284761 [TBL] [Abstract][Full Text] [Related]
20. Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms. Haab BB; Porter A; Yue T; Li L; Scheiman J; Anderson MA; Barnes D; Schmidt CM; Feng Z; Simeone DM Ann Surg; 2010 May; 251(5):937-45. PubMed ID: 20395854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]